CurveBeam AI Limited Stock

Equities

CVB

AU0000289761

Advanced Medical Equipment & Technology

Delayed Australian S.E. 08:52:40 2024-06-02 pm EDT 5-day change 1st Jan Change
0.175 AUD -2.78% Intraday chart for CurveBeam AI Limited +2.94% -57.83%
Sales 2024 * 11.19M 7.45M Sales 2025 * 26.6M 17.72M Capitalization 57.62M 38.37M
Net income 2024 * -23M -15.32M Net income 2025 * -13M -8.66M EV / Sales 2024 * 3.16 x
Net cash position 2024 * 22.21M 14.79M Net cash position 2025 * 21.25M 14.15M EV / Sales 2025 * 1.37 x
P/E ratio 2024 *
-0.43 x
P/E ratio 2025 *
-3.4 x
Employees 50
Yield 2024 *
-
Yield 2025 *
-
Free-Float 27.79%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.78%
1 week+2.94%
Current month-2.78%
1 month-5.41%
3 months-16.67%
6 months-43.55%
Current year-57.83%
More quotes
1 week
0.16
Extreme 0.16
0.19
1 month
0.14
Extreme 0.14
0.19
Current year
0.14
Extreme 0.14
0.40
1 year
0.14
Extreme 0.14
0.55
3 years
0.14
Extreme 0.14
0.55
5 years
0.14
Extreme 0.14
0.55
10 years
0.14
Extreme 0.14
0.55
More quotes
Date Price Change Volume
24-06-02 0.175 -2.78% 13 888
24-05-31 0.18 0.00% 20,567
24-05-30 0.18 -2.70% 145,674
24-05-29 0.185 +15.62% 313,199
24-05-28 0.16 -5.88% 264,277

Delayed Quote Australian S.E., June 02, 2024 at 08:52 pm EDT

More quotes
Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The Company is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.18 AUD
Average target price
0.47 AUD
Spread / Average Target
+161.11%
Consensus

Annual profits - Rate of surprise